| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/16/2005 | US20050130911 Nucleic acid-lipophilic conjugates |
| 06/16/2005 | US20050130903 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 06/16/2005 | US20050130900 Sustained release drug formulations containing a carrier peptide |
| 06/16/2005 | US20050130240 Mannose enclosed metallic nanoparticles for use as diagnostic and drug delivery tools |
| 06/16/2005 | US20050130207 Cluster complex or colloid comprised of metal core particle and probes for visualizing the localization or distribution of substances within cells, tissue sections, organelles or organs |
| 06/16/2005 | US20050130181 RNA interference mediated inhibition of wingless gene expression using short interfering nucleic acid (siNA) |
| 06/16/2005 | US20050129806 Hydrolysis of pyrodextrin with amylase; chewing gum, candy, drugs |
| 06/16/2005 | US20050129774 Mixture with surfactant and another drug; analgesics; antiinflammatory agents |
| 06/16/2005 | US20050129771 Ophthalmic compositions containing a polysaccharide/borate gelling system |
| 06/16/2005 | US20050129769 Hydrophilic polymeric nanoparticles; scaffold for drug; using n-cystinebisacrylamide |
| 06/16/2005 | US20050129761 Pantoprazole multiparticulate formulations |
| 06/16/2005 | US20050129760 Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline cellulose and a method for its preparation |
| 06/16/2005 | US20050129757 Process for producing solid dosage forms |
| 06/16/2005 | US20050129756 UV-stable, liquid or semisolid transdermal pharmaceutical preparation with light sensitive active ingredient |
| 06/16/2005 | US20050129754 Halogenated anesthetic in emulsion with lecithin |
| 06/16/2005 | US20050129751 Controlled release of drug |
| 06/16/2005 | US20050129738 Infant formula supplemented with phospholipids |
| 06/16/2005 | US20050129737 Devices and methods for pain management |
| 06/16/2005 | US20050129736 Compositions and methods for treating or preventing diseases of body passageways |
| 06/16/2005 | US20050129734 Hydrogel entrapping therapeutic agent and stent with coating comprising this |
| 06/16/2005 | US20050129722 For an active substance, characterized by enhancing skin barrier restoration in the stratum corneum comprising a fatty acid, cholesterol, a ceramide and at least one skin lipid precursor; topical drug delivery |
| 06/16/2005 | US20050129721 Refrigerant composition, refrigerant auxiliary compositions and uses thereof |
| 06/16/2005 | US20050129719 Concentrated emulsion formulation for silatecan |
| 06/16/2005 | US20050129718 Pharmaceutical compositions comprising a cyclosporin, a hydrophilic surfactant and a lipophilic surfactant |
| 06/16/2005 | US20050129706 Bonded to polyethylene glycol through a linking group, wherein the arginine deiminase is derived from Streptococcus, Borrelia, Giardia, Clostridium, Enterococcus, Lactobacillus, or Bacillus; improved tumoricidal activity; anticarcinogenic, antitumor, antimetastasis agents; melanoma |
| 06/16/2005 | US20050129668 Methods, instruments and materials for chondrocyte cell transplantation |
| 06/16/2005 | US20050129625 Aerosolizing dry powder of interleukin-4 receptor with carbohydrage, lipid, buffer, peptide, protein, Group II metal, or oligopeptide excipient; small aerodynamic particle size; dispersion into gas stream to make inhalant |
| 06/16/2005 | US20050129624 Methods of treating conditions with a metal-containing material |
| 06/16/2005 | US20050129623 Inhalable aztreonam aerosol for treatment and prevention of pulmonary bacterial infections |
| 06/16/2005 | US20050129622 Nasal composition comprising a mucopolysaccharide and propylene glycol |
| 06/16/2005 | US20050129621 Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect |
| 06/16/2005 | US20050126886 Method and apparatus for transferring substrates |
| 06/16/2005 | DE60103627T2 SELBSTEMULGIERENDES ARZNEISTOFFVERABREICHUNGSSYSTEM, wobei das Fettmittel optional ist A self-DRUG ADMINISTRATION SYSTEM, wherein the fat means is optional |
| 06/16/2005 | DE10353196A1 Mehrschichtige Arzneiform mit einer die Abgabe einer modulatorischen Substanz beeinflussenden Matrix Multilayer dosage form with the delivery of a modulatory substance influencing matrix |
| 06/16/2005 | DE10350248A1 Thermosensitive, biokompatible Polymerträger mit veränderbarer physikalischer Struktur für die Therapie, Diagnostik und Analytik Thermosensitive biocompatible polymer support with variable physical structure for therapy, diagnostics and analytics |
| 06/16/2005 | DE10348550A1 Stabile wässrige G-CSF-haltige Zusammensetzungen A stable aqueous G-CSF-containing compositions |
| 06/16/2005 | CA2547594A1 Method for treatment of solid pharmaceutical preparation prior to printing and solid pharmaceutical preparation subjected to treatment prior to printing |
| 06/16/2005 | CA2547545A1 Novel cyclodextrin dimers and their derivatives, their preparation processes and use, specifically for solubilising pharmacologically active substances |
| 06/16/2005 | CA2547255A1 Releasable linkage and compositions containing same |
| 06/16/2005 | CA2546452A1 Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens |
| 06/16/2005 | CA2545271A1 Association of antimicrobial compounds with surfaces and polymers |
| 06/16/2005 | CA2544890A1 Drug delivery vehicles and uses thereof |
| 06/16/2005 | CA2544888A1 Rgd targeting moiety its production and use |
| 06/16/2005 | CA2543577A1 Sprayable composition for the administration of vitamin d derivatives |
| 06/15/2005 | EP1541660A1 Radical reaction inhibitors, method for inhibition of radical reactions, and use thereof |
| 06/15/2005 | EP1541554A1 Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same |
| 06/15/2005 | EP1541544A1 Method of preparing hydroxytyrosol esters, esters thus obtained and use of same |
| 06/15/2005 | EP1541177A1 Adhesive patch |
| 06/15/2005 | EP1541176A1 Adhesive patch |
| 06/15/2005 | EP1541161A1 Tablet composition containing chinese orthodox medicine extract and process for producing the same |
| 06/15/2005 | EP1541155A1 Carbon dioxide external preparation and material for formation of carbon dioxide external preparation |
| 06/15/2005 | EP1541144A1 Indometacin preparation for external use |
| 06/15/2005 | EP1541136A1 UV light-stable semi-solid transdermal systems comprising a photosensitive active agent and an UV-absorbing component |
| 06/15/2005 | EP1541135A1 Hollow nanoparticle having modified cysteine residue and drug with the use thereof |
| 06/15/2005 | EP1541134A2 Stabilized azithromycin compositions |
| 06/15/2005 | EP1541130A1 Chinese herb medicine composition in the form of jelly |
| 06/15/2005 | EP1541126A1 Cosmetic and dermatological composition comprising a combination of a green colouring agent and an antiinflammatory agent |
| 06/15/2005 | EP1541125A1 Spreadable compositions for topical use, a process of making same and uses thereof |
| 06/15/2005 | EP1541121A1 System and process for releasing encapsulated active ingredients |
| 06/15/2005 | EP1539976A2 Method for producing biodegradable, functionalised polymer particles, and use of the same as medicament carriers |
| 06/15/2005 | EP1539941A2 Adzymes and uses thereof |
| 06/15/2005 | EP1539856A1 Polyalkylene glycols, derivatives and conjugates thereof in particulate form |
| 06/15/2005 | EP1539823A1 Obtaining and use of therapeutic antibodies entering into the cell |
| 06/15/2005 | EP1539818A2 Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells |
| 06/15/2005 | EP1539811A2 Production of bispecific molecules using polyethylene glycol linkers |
| 06/15/2005 | EP1539799A2 Crosslinked compounds and methods of making and using thereof |
| 06/15/2005 | EP1539780A1 Derivatives of monosaccharides for drug discovery |
| 06/15/2005 | EP1539739A1 Piperidinyl compounds that selectively bind integrins |
| 06/15/2005 | EP1539664A1 Crystallization of polyol compositions, crystalline polyol composition product and use thereof |
| 06/15/2005 | EP1539284A2 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 06/15/2005 | EP1539282A2 Improved injection system |
| 06/15/2005 | EP1539252A2 Blood clot-targeted nanoparticles |
| 06/15/2005 | EP1539245A2 Methods and materials for treating human papillomavirus infections |
| 06/15/2005 | EP1539244A1 Use of dimethyl sulfone as isotonicity agent |
| 06/15/2005 | EP1539243A2 Ether alcohols used as solvents and emulsifiers and dispersions containing said ether alcohols |
| 06/15/2005 | EP1539241A2 Method of controlling pharmacokinetics of immunomodulatory compounds |
| 06/15/2005 | EP1539239A2 A novel stable formulation |
| 06/15/2005 | EP1539222A1 Treatment for eye disorder |
| 06/15/2005 | EP1539220A2 Compositions and method for enhanced mucosal delivery of interferon beta |
| 06/15/2005 | EP1539212A2 Methods and compositions for preventing oxidative degradation of proteins |
| 06/15/2005 | EP1539208A2 Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
| 06/15/2005 | EP1539201A1 Antipyrotic and method of manufacturing the same |
| 06/15/2005 | EP1539193A1 Compositions of hyaluronic acid and methods of use |
| 06/15/2005 | EP1539192A1 Composition and kit for the treatment of inflammatory bowel diseases |
| 06/15/2005 | EP1539170A2 Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof |
| 06/15/2005 | EP1539165A1 Sustained-release tablet composition comprising a dopamine receptor agonist |
| 06/15/2005 | EP1539155A1 Stable cream preparations of phenyl-pyridone compounds for topical application |
| 06/15/2005 | EP1539148A2 Bicifadine formulation |
| 06/15/2005 | EP1539130A1 Percutaneous and perungual delivery system |
| 06/15/2005 | EP1539122A2 Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
| 06/15/2005 | EP1539119A1 Palatable controlled-release formulation for companion animals |
| 06/15/2005 | EP1539114A1 Film coating for tablets and caplets |
| 06/15/2005 | EP1539113A2 Modified release ketoprofen dosage form |
| 06/15/2005 | EP1539103A2 Methods of treating idiopathic pulmonary fibrosis |
| 06/15/2005 | EP1539101A2 Injectable multimodal polymer depot compositions and uses thereof |
| 06/15/2005 | EP1539099A2 Reversed liquid crystalline phases with non-paraffin hydrophobes |
| 06/15/2005 | EP1539097A1 Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma |
| 06/15/2005 | EP1539096A1 New sexual-dysfunction-compound-containing rapid-onset pharmaceutical formulations comprising cocoa powder and use thereof |
| 06/15/2005 | EP1539069A1 Transmucosal delivery of cannabinoids |
| 06/15/2005 | EP1539041A1 Devices delivering therapeutic agents and methods regarding the same |